AUTHOREA
Log in Sign Up Browse Preprints

September 25, 2024
Endocrine toxicities in Chimeric Antigen Receptor T-Cell Therapy: A pharmacovigilance...
jizhou liang, Fangyuan Hu, Yinghong Zhai, et al.
September 06, 2023
Data mining and analysis for Nilotinib adverse event signals based on the Food and Dr...
Zhiyu Yang, Xiaofei Ye, Xinyu Dong, et al.
May 31, 2023
Safety of Interleukin-23 Inhibitor: A Pharmacovigilance Study From 2014 to 2022 Based...
Wentao Shi, Yinghong Zhai, Ziyi Zhao, et al.
March 21, 2023
Nephrotoxicity of low-osmolar and iso-osmolar iodinated contrast media -- a pharmacov...
zhang hewei, Yue Li, Xiaofei Ye, et al.
March 20, 2022
Safety of sugammadex for reversal of neuromuscular block: a post-marketing study base...
Qiang Lyu, Pei Ye, Hewei Zhang, et al.
May 15, 2021
Safety of SGLT2 Inhibitors: A Pharmacovigilance Study From 2015 to 2020 Based on FDA...
Xiang Zhou, Xiaofei Ye, Yinghong Zhai, et al.